Search

everythinglearnresearchcommunity

for

Search:↓

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Women with excessive hair growth tend to have shorter index and ring fingers compared to others.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Rosemary leaf extract may be an effective natural treatment for hair growth and male pattern baldness.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Estrogen can temporarily slow down hair growth but this can be reversed.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The normal human prostate does not significantly affect blood DHT levels.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Finasteride helps induce ovulation in nonresponder PCOS women.